Cargando…
The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series
CNS lymphoma often presents with atypical imaging characteristics leading to delay in diagnosis and initiation of treatment. Among the most rarely reported of these is entirely nonenhancing CNS lymphoma, which is estimated at an incidence of about 1%. Here, we present three cases of nonenhancing CNS...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962175/ https://www.ncbi.nlm.nih.gov/pubmed/33322942 http://dx.doi.org/10.2217/cns-2020-0020 |
_version_ | 1783665417504423936 |
---|---|
author | Bowden, Stephen G Munger, Daniel N Thiessen, Jaclyn Woll, S Cody Schoettler Han, Seunggu J Neuwelt, Edward A Barajas, Ramon F Ambady, Prakash |
author_facet | Bowden, Stephen G Munger, Daniel N Thiessen, Jaclyn Woll, S Cody Schoettler Han, Seunggu J Neuwelt, Edward A Barajas, Ramon F Ambady, Prakash |
author_sort | Bowden, Stephen G |
collection | PubMed |
description | CNS lymphoma often presents with atypical imaging characteristics leading to delay in diagnosis and initiation of treatment. Among the most rarely reported of these is entirely nonenhancing CNS lymphoma, which is estimated at an incidence of about 1%. Here, we present three cases of nonenhancing CNS lymphoma in immune competent patients at both initial presentation and recurrence and in primary as well as secondary CNS lymphoma. Diffusion- and perfusion-weighted imaging was found helpful in diagnosis in some cases. |
format | Online Article Text |
id | pubmed-7962175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-79621752021-03-19 The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series Bowden, Stephen G Munger, Daniel N Thiessen, Jaclyn Woll, S Cody Schoettler Han, Seunggu J Neuwelt, Edward A Barajas, Ramon F Ambady, Prakash CNS Oncol Case Series CNS lymphoma often presents with atypical imaging characteristics leading to delay in diagnosis and initiation of treatment. Among the most rarely reported of these is entirely nonenhancing CNS lymphoma, which is estimated at an incidence of about 1%. Here, we present three cases of nonenhancing CNS lymphoma in immune competent patients at both initial presentation and recurrence and in primary as well as secondary CNS lymphoma. Diffusion- and perfusion-weighted imaging was found helpful in diagnosis in some cases. Future Medicine Ltd 2020-12-16 /pmc/articles/PMC7962175/ /pubmed/33322942 http://dx.doi.org/10.2217/cns-2020-0020 Text en © 2020 Prakash Ambady This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Case Series Bowden, Stephen G Munger, Daniel N Thiessen, Jaclyn Woll, S Cody Schoettler Han, Seunggu J Neuwelt, Edward A Barajas, Ramon F Ambady, Prakash The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series |
title | The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series |
title_full | The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series |
title_fullStr | The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series |
title_full_unstemmed | The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series |
title_short | The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case series |
title_sort | clinical heterogeneity of entirely nonenhancing cns lymphoma: a case series |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962175/ https://www.ncbi.nlm.nih.gov/pubmed/33322942 http://dx.doi.org/10.2217/cns-2020-0020 |
work_keys_str_mv | AT bowdenstepheng theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT mungerdanieln theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT thiessenjaclyn theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT wollscodyschoettler theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT hanseungguj theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT neuweltedwarda theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT barajasramonf theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT ambadyprakash theclinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT bowdenstepheng clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT mungerdanieln clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT thiessenjaclyn clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT wollscodyschoettler clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT hanseungguj clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT neuweltedwarda clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT barajasramonf clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries AT ambadyprakash clinicalheterogeneityofentirelynonenhancingcnslymphomaacaseseries |